Transdermal Drug Delivery System Market - Forecasts from 2018 to 2023
The global transdermal drug delivery system market is estimated to register a CAGR of 8.91% over the forecast period of 2017-2023. Transdermal drug delivery involves delivering the drug the medications in systemic circulation through skin at a controlled rate, thereby, maintaining effective plasma level concentration of the drug in body over prolong period of time. The drugs are usually applied in the form of ointment, patches or plaster which is then absorbed into the systemic circulation. Skin age, condition, physicochemical factors and environmental factors are some factors that are to be considered while delivering drug through this route. The drug delivery is non-invasive and bypass first pass metabolism, thus, increasing the bioavailability of the drug. The rise in the market is attributed to the rising adoption of the TDDS due to the various advantages offered by TDDS such as prolonged therapeutic effect, reduced side-effects, improved bioavailability, better patient compliance and easy termination of drug therapy. However, inability of the skin to absorb large range of medications will restrain the market during the forecast period.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global transdermal drug delivery system market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global transdermal drug delivery system market.
Major industry players profiled as part of the report are 3M, Zosano Pharma Corporation, Tesa Labtec GmbH and Tapemark among others.
Segmentation
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global transdermal drug delivery system market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global transdermal drug delivery system market.
Major industry players profiled as part of the report are 3M, Zosano Pharma Corporation, Tesa Labtec GmbH and Tapemark among others.
Segmentation
- By Type
- Patches
- Gels and Ointments
- By Application
- Neurologic Conditions
- Pain Management
- Nicotine Cessation
- Cardiovascular
- Others
- By End-Users
- Hospitals and Clinics
- Surgical Centers
- Home Care Settings
- By Geography
- North America
- United States
- Canada
- Others
- South America
- Brazil
- Argentina
- Others
- Europe
- United Kingdom
- Germany
- France
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Others
- Asia Pacific
- China
- India
- Australia
- South Korea
- Others
1. INTRODUCTION
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FORECAST BY TYPE
5.1. Patches
5.2. Gels and Ointments
6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FORECAST BY APPLICATION
6.1. Neurologic Conditions
6.2. Pain Management
6.3. Nicotine Cessation
6.4. Cardiovascular
6.5. Others
7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FORECAST BY APPLICATION
7.1. Hospitals and Clinics
7.2. Surgical Centers
7.3. Home Care Settings
8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FORECAST BY GEOGRAPHY
8.1. North America
8.1.1. U.S.
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. 3M
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Developments
10.2. ProSolus, Inc.
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Developments
10.3. Zosano Pharma Corporation
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Developments
10.4. MedPharm
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Developments
10.5. Tesa Labtec GmbH
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Developments
10.6. Medherant Limited
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Developments
10.7. Tapemark
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Developments
10.8. Toyochem Co. Ltd.
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Developments
10.9. Delivra Corp
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Developments
10.10. Epinamics GmbH
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Developments
List of Figures
List of Tables
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FORECAST BY TYPE
5.1. Patches
5.2. Gels and Ointments
6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FORECAST BY APPLICATION
6.1. Neurologic Conditions
6.2. Pain Management
6.3. Nicotine Cessation
6.4. Cardiovascular
6.5. Others
7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FORECAST BY APPLICATION
7.1. Hospitals and Clinics
7.2. Surgical Centers
7.3. Home Care Settings
8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FORECAST BY GEOGRAPHY
8.1. North America
8.1.1. U.S.
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. 3M
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Developments
10.2. ProSolus, Inc.
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Developments
10.3. Zosano Pharma Corporation
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Developments
10.4. MedPharm
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Developments
10.5. Tesa Labtec GmbH
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Developments
10.6. Medherant Limited
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Developments
10.7. Tapemark
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Developments
10.8. Toyochem Co. Ltd.
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Developments
10.9. Delivra Corp
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Developments
10.10. Epinamics GmbH
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Developments
List of Figures
List of Tables
